
Sign up to save your podcasts
Or


Send us Fan Mail
Editor-in-Chief, Robert Amdur, MD, discusses radiotherapy dose prescription to positive pelvic or paraaortic nodes when treating a cervix cancer patient with primary chemo-radiotherapy. The discussion is based on a paper published in the May 2023 issue of PRO titled "Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Cancer" (2023, Issue 3, May/June, PMID: 35529239). In this paper, three radiation oncologists with subspecialty experience in GYN oncology summarize relevant studies and then list the dose schedules they currently use.
By Various4.6
3838 ratings
Send us Fan Mail
Editor-in-Chief, Robert Amdur, MD, discusses radiotherapy dose prescription to positive pelvic or paraaortic nodes when treating a cervix cancer patient with primary chemo-radiotherapy. The discussion is based on a paper published in the May 2023 issue of PRO titled "Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Cancer" (2023, Issue 3, May/June, PMID: 35529239). In this paper, three radiation oncologists with subspecialty experience in GYN oncology summarize relevant studies and then list the dose schedules they currently use.
30,763 Listeners

4,125 Listeners

5,105 Listeners

2,451 Listeners

112,309 Listeners

56,624 Listeners

6,076 Listeners

61 Listeners

228 Listeners

6,410 Listeners

1,251 Listeners

196 Listeners

37 Listeners

10 Listeners

0 Listeners